Last reviewed · How we verify
Jojoba
At a glance
| Generic name | Jojoba |
|---|---|
| Sponsor | University of Rochester |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
Common side effects
Key clinical trials
- Evaluating the Feasibility and Acceptability of Inhalation Aromatherapy for Reducing Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients Undergoing Autologous Haematopoietic Stem Cell Transpla (NA)
- Aromatherapy for Management of Chemotherapy-induced Symptoms (EARLY/Phase 1)
- Aromatherapy: An Integrative Option for Symptom Management in Cancer Care (NA)
- Assessing the Feasibility of Aromatherapy Essential Oil Associated Changes on Nausea in Patients Receiving Infusion in the Ambulatory Setting (NA)
- Evaluating Skin Barrier Biophysical Properties and Clinical Appearance After Moisturizer Use in Patients With Dry Skin (NA)
- Lavender Oil Aromatherapy for The Treatment of Acute Anxiety During Bone Marrow Biopsy Procedures (NA)
- Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin (Phase 1)
- A Preliminary Investigation of the Efficacy of Aromatherapy in Reducing Discomfort in Youth With Chronic Headache (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Jojoba CI brief — competitive landscape report
- Jojoba updates RSS · CI watch RSS
- University of Rochester portfolio CI